Skip to content

Daniel Schneeberger, 10% owner at InMed Pharmaceuticals, bought INM on Sep 16, 2026

Data as of Oct 16

▲ BUY$10.8K8,340 shares at $1.29Daniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.
Watch INM
Traded
Sep 16, 2026
Disclosed
Sep 16, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Daniel Schneeberger, 10% owner at InMed Pharmaceuticals, bought INM on Sep 16, 2026TRADEDDISCLOSED
INMSimilar stocks (XLV — its sector index fund), rebased to INM's price on the disclosure day
INM since disclosure
+3.1%
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund

Change in closing price from Sep 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$10.8Kdisclosed Sep 16 · filed the same day
  2. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  3. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  4. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$36.9Kdisclosed Sep 16 · filed 2 days after the trade
  5. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$36.9Kdisclosed Sep 16 · filed 2 days after the trade

See every trade on INM →